Abstract

Simple SummaryThe traditional process of drug development is lengthy, time-consuming, and costly, whereas very few drugs ever make it to the clinic. The use of computational methods to detect drug side effects greatly reduces the deficiencies in drug clinical trials. Prediction of drug-target interactions is a key step in drug discovery and repositioning. In this article, we proposed a novel method for the prediction of drug-target interactions based on large-scale graph representation learning. This method can be helpful to researchers in clinical trials and drug research and development.Identification of drug-target interactions (DTIs) is a significant step in the drug discovery or repositioning process. Compared with the time-consuming and labor-intensive in vivo experimental methods, the computational models can provide high-quality DTI candidates in an instant. In this study, we propose a novel method called LGDTI to predict DTIs based on large-scale graph representation learning. LGDTI can capture the local and global structural information of the graph. Specifically, the first-order neighbor information of nodes can be aggregated by the graph convolutional network (GCN); on the other hand, the high-order neighbor information of nodes can be learned by the graph embedding method called DeepWalk. Finally, the two kinds of feature are fed into the random forest classifier to train and predict potential DTIs. The results show that our method obtained area under the receiver operating characteristic curve (AUROC) of 0.9455 and area under the precision-recall curve (AUPR) of 0.9491 under 5-fold cross-validation. Moreover, we compare the presented method with some existing state-of-the-art methods. These results imply that LGDTI can efficiently and robustly capture undiscovered DTIs. Moreover, the proposed model is expected to bring new inspiration and provide novel perspectives to relevant researchers.

Highlights

  • We propose a novel method to predict drug-target interactions (DTIs) based on large-scale graph representation learning (LGDTI)

  • The accurate and efficient computational model could greatly accelerate the process of identification of DTIs, there is still a huge gap between academia and industry

  • We developed a novel method called LGDTI for predicting DTIs

Read more

Summary

Introduction

Drug repositioning is the process of exploring the new effects of existing drugs except for the original indications for medical treatment. It is a direction with great opportunities and challenges. It has the advantages of low-cost, short-time and low-risk [1,2]. The drug-target interactions (DTIs) play an important role in drug discovery and drug repositioning. Accurate prediction of DTIs can improve the accuracy of drug clinical trials, greatly reducing the risks of experiments.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call